The Poly (ADP-Ribose) Polymerase Inhibitor Veliparib and Radiation Cause Significant Cell Line Dependent Metabolic Changes in Breast Cancer Cells

Breast tumors are characterized into subtypes based on their surface marker expression, which affects their prognosis and treatment. Poly (ADP-ribose) polymerase (PARP) inhibitors have shown promising results in clinical trials, both as single agents and in combination with other chemotherapeutics,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhute, Vijesh J., Ma, Yan, Bao, Xiaoping, Palecek, Sean P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095763/
https://www.ncbi.nlm.nih.gov/pubmed/27811964
http://dx.doi.org/10.1038/srep36061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095763/
https://www.ncbi.nlm.nih.gov/pubmed/27811964
http://dx.doi.org/10.1038/srep36061

Ejemplares similares